Loading...

loading icon

Why This Colorado Law Firm Is Upset Over DEA’s Rescheduling of CBD Medication

by / No Comments / 0 View / October 3, 2018

By Toke of the Town

The Drug Enforcement Administration appeared to take a large step forward on Thursday, September 27, when it confirmed that it would reclassify Epidiolex as a Schedule V substance. The move follows Food and Drug Administration approval and classifies the marijuana-derived cannabidiol (CBD) medication under the DEA’s lowest restriction for drugs, so physicians and pharmacies can […]

The post Why This Colorado Law Firm Is Upset Over DEA’s Rescheduling of CBD Medication appeared first on Toke of the Town.

…read more

Via: Why This Colorado Law Firm Is Upset Over DEA’s Rescheduling of CBD Medication